Camp4 Therapeutics Corp Sustainability Reports
A clinical-stage biopharmaceutical company focused on discovering and developing regulatory RNA-based therapeutics. The company leverages its proprietary RAP Platform to map regulatory RNAs and upregulate gene expression to treat a broad range of genetic diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00L2CHQ99
1 reports from 2024 to 2024
Company Profile
A clinical-stage biopharmaceutical company focused on discovering and developing regulatory RNA-based therapeutics. The company leverages its proprietary RAP Platform to map regulatory RNAs and upregulate gene expression to treat a broad range of genetic diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
